Forging better lives: Seeking radical change for cancers

For more than 500,000 people living with stage four breast, ovarian and endometrial cancers, death often occurs within 12-48 months, often with a low quality of life. These conditions, predominantly affecting women, simply have no cure.

Context Therapeutics’ mission is to radically change this devastating reality. 

In this film, co-founder and CEO Marty Lehr explains Context’s commercial and operating models and why he believes they reduce risk and have the potential to increase value creation for the business and its investors.

Want to receive content on Context Therapeutics? Complete the form below.